The estimated Net Worth of Jenny Herman is at least $642 Thousand dollars as of 12 February 2024. Jenny Herman owns over 787 units of Schrodinger stock worth over $242,041 and over the last 5 years Jenny sold SDGR stock worth over $400,164.
Jenny has made over 7 trades of the Schrodinger stock since 2020, according to the Form 4 filled with the SEC. Most recently Jenny sold 787 units of SDGR stock worth $22,264 on 12 February 2024.
The largest trade Jenny's ever made was exercising 4,545 units of Schrodinger stock on 15 September 2023 worth over $5,454. On average, Jenny trades about 879 units every 111 days since 2020. As of 12 February 2024 Jenny still owns at least 11,761 units of Schrodinger stock.
You can see the complete history of Jenny Herman stock trades at the bottom of the page.
Jenny's mailing address filed with the SEC is C/O SCHRODINGER, INC.,, 1540 BROADWAY, 24TH FLOOR, NEW YORK, NY, 10036.
Over the last 5 years, insiders at Schrodinger have traded over $1,009,056,149 worth of Schrodinger stock and bought 838,235 units worth $14,249,995 . The most active insiders traders include & Melinda Gates Foundation ..., David E Schrodinger Equity ..., and Michael Lynton. On average, Schrodinger executives and independent directors trade stock every 10 days with the average trade being worth of $2,459,207. The most recent stock trade was executed by Kenneth Patrick Lorton on 6 March 2024, trading 5,574 units of SDGR stock currently worth $24,191.
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Schrodinger executives and other stock owners filed with the SEC include: